Literature DB >> 22448005

Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome.

Alex Ray1, Vickie Marshall, Thomas Uldrick, Robert Leighty, Nazzarena Labo, Kathy Wyvill, Karen Aleman, Mark N Polizzotto, Richard F Little, Robert Yarchoan, Denise Whitby.   

Abstract

BACKGROUND: Kaposi sarcoma-associated herpesvirus (KSHV) encodes 12 pre-microRNAs that yield 25 mature microRNAs. We previously reported phylogenetic analysis of the microRNA-coding region of KSHV from Kaposi sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman disease (MCD) patients. We observed a high level of conservation for most sequences but also a divergent cluster of 5 KSHV sequences, including 2 from MCD patients.
METHODS: KSHV microRNA sequences from 23 MCD patients and 7 patients with a newly described KSHV-associated inflammatory cytokine syndrome (KICS) were examined by amplification, cloning, and sequencing of a 646-bp fragment of K12/T0.7 encoding microRNA-K12-10 and microRNA-K12-12 and a 2.8-kbp fragment containing the remaining 10 pre-microRNAs.
RESULTS: Phylogenetic analysis showed a distinct variant cluster consisting exclusively of MCD and KICS patients in all trees. Pearson χ(2) analysis revealed that 40 single-nucleotide polymorphisms (SNPs) at various loci were significantly associated with MCD and KICS risk. Cluster analysis of these SNPs generated several combinations of 3 SNPs as putative indicators of MCD and KICS risk.
CONCLUSIONS: These findings show that MCD and KICS patients frequently have unusual KSHV microRNA sequences and suggest an association between the observed sequence variation and risk of MCD and KICS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22448005      PMCID: PMC3415855          DOI: 10.1093/infdis/jis249

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  44 in total

1.  A quantification of human cells using an ERV-3 real time PCR assay.

Authors:  C C Yuan; W Miley; D Waters
Journal:  J Virol Methods       Date:  2001-02       Impact factor: 2.014

Review 2.  Molecular piracy of Kaposi's sarcoma associated herpesvirus.

Authors:  J Choi; R E Means; B Damania; J U Jung
Journal:  Cytokine Growth Factor Rev       Date:  2001 Jun-Sep       Impact factor: 7.638

3.  microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis.

Authors:  Aaron E Hoffman; Tongzhang Zheng; Chunhui Yi; Derek Leaderer; Joanne Weidhaas; Frank Slack; Yawei Zhang; Trupti Paranjape; Yong Zhu
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

4.  Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders.

Authors:  Y Aoki; R Yarchoan; K Wyvill; S Okamoto ; R F Little; G Tosato
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

5.  High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

Authors:  E Oksenhendler; G Carcelain; Y Aoki; E Boulanger; A Maillard; J P Clauvel; F Agbalika
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

6.  Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes.

Authors:  Zhiqiang Qin; Patricia Kearney; Karlie Plaisance; Chris H Parsons
Journal:  J Leukoc Biol       Date:  2010-01       Impact factor: 4.962

7.  Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs.

Authors:  Meiqun Wu; Normand Jolicoeur; Zhen Li; Linhua Zhang; Yves Fortin; Denis L'Abbe; Zhenbao Yu; Shi-Hsiang Shen
Journal:  Carcinogenesis       Date:  2008-03-19       Impact factor: 4.944

8.  Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells.

Authors:  Daphna Nachmani; Noam Stern-Ginossar; Ronit Sarid; Ofer Mandelboim
Journal:  Cell Host Microbe       Date:  2009-04-23       Impact factor: 21.023

9.  Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs.

Authors:  Joseph M Ziegelbauer; Christopher S Sullivan; Don Ganem
Journal:  Nat Genet       Date:  2008-12-21       Impact factor: 38.330

10.  Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation.

Authors:  Priya Bellare; Don Ganem
Journal:  Cell Host Microbe       Date:  2009-12-17       Impact factor: 21.023

View more
  19 in total

1.  Kaposi's sarcoma-associated herpesvirus microRNA single-nucleotide polymorphisms identified in clinical samples can affect microRNA processing, level of expression, and silencing activity.

Authors:  Soo-Jin Han; Vickie Marshall; Eugene Barsov; Octavio Quiñones; Alex Ray; Nazzarena Labo; Matthew Trivett; David Ott; Rolf Renne; Denise Whitby
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

2.  Are There Clues to Oral Kaposi Sarcoma-Associated Herpesvirus Shedding and Kaposi Sarcoma Oncogenesis in the Oral Microbiome?

Authors:  Richard F Little; Thomas S Uldrick
Journal:  J Infect Dis       Date:  2020-03-28       Impact factor: 5.226

3.  Kaposi's Sarcoma-associated Herpesvirus microRNA mutants modulate cancer hallmark phenotypic differences in human endothelial cells.

Authors:  Lauren A Gay; Daniel Stribling; Peter C Turner; Rolf Renne
Journal:  J Virol       Date:  2021-02-10       Impact factor: 5.103

4.  Naturally arising strains of polyomaviruses with severely attenuated microRNA expression.

Authors:  Chun Jung Chen; James M Burke; Rodney P Kincaid; Kristopher D Azarm; Noel Mireles; Janet S Butel; Christopher S Sullivan
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

Review 5.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

Review 6.  HIV-associated Kaposi sarcoma and related diseases.

Authors:  Priscila H Gonçalves; Thomas S Uldrick; Robert Yarchoan
Journal:  AIDS       Date:  2017-09-10       Impact factor: 4.177

Review 7.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

8.  Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).

Authors:  Mark N Polizzotto; Thomas S Uldrick; Kathleen M Wyvill; Karen Aleman; Vickie Marshall; Victoria Wang; Denise Whitby; Stefania Pittaluga; Elaine S Jaffe; Corina Millo; Giovanna Tosato; Richard F Little; Seth M Steinberg; Irini Sereti; Robert Yarchoan
Journal:  Clin Infect Dis       Date:  2015-12-12       Impact factor: 9.079

9.  Kaposi's sarcoma-associated herpesvirus encodes a mimic of cellular miR-23.

Authors:  Mark Manzano; Priscilla Shamulailatpam; Archana N Raja; Eva Gottwein
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

Review 10.  Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)--an update.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  Curr Opin Virol       Date:  2013-06-13       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.